Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc.

Biotechnology • Healthcare • South San Francisco, CA, United States • KZR (NCM)

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

650 822 5600 4000 Shoreline Court, South San Francisco, CA 94080, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Kezar Life Sciences (KZR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Yahoo Finance • Jan 5
Kezar Life Sciences Stock Hit With Downgrades And Price Target Cuts: Retail Keeps Hopes Alive - Stocktwits
Stocktwits • Oct 17
Kezar Life Sciences stock climbs as company seeks strategic alternatives - Investing.com
Investing.com • Oct 16
Kezar Life Sciences to lay off 70% of workforce as dispute with FDA apparently continues - The Business Journals
The Business Journals • Nov 10
Kezar plans layoffs after FDA cancels meeting to discuss next trial - Fierce Biotech
Fierce Biotech • Oct 17

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Kezar Life Sciences, Inc. had layoffs?
No layoff events have been recorded for Kezar Life Sciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Kezar Life Sciences, Inc. have?
Kezar Life Sciences, Inc. has approximately 55 employees.
What industry is Kezar Life Sciences, Inc. in?
Kezar Life Sciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Kezar Life Sciences, Inc. a publicly traded company?
Yes, Kezar Life Sciences, Inc. is publicly traded under the ticker symbol KZR on the NCM. The company has a market capitalization of approximately $0.05 billion.
Where is Kezar Life Sciences, Inc. headquartered?
Kezar Life Sciences, Inc. is headquartered in South San Francisco, CA, United States at 4000 Shoreline Court, South San Francisco, CA 94080, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.